Posts Tagged ‘Acorda Therapeutics Inc (ACOR)’

Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Nektar Therapeutics (NASDAQ:NKTR)
Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment......(read more)

Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Acorda Therapeutics Inc (NASDAQ:ACOR)
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds......(read more)

Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc
Is it smart to be bullish on Sarepta Therapeutics Inc (NASDAQ:SRPT)? If you were to ask many of your fellow readers, hedge funds are seen as overrated......(read more)

Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Who’s crazy about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)? If you were to ask many market players, hedge funds are seen as useless, outdated......(read more)

Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view. The number of bullish......(read more)

Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?

Nektar Therapeutics (NASDAQ:NKTR)
Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds’ portfolio at the end of March. NKTR has experienced a decrease in support from the world......(read more)

This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds’ portfolio at the end of March. SRPT shareholders have witnessed an increase in enthusiasm......(read more)

Idenix Pharmaceuticals Inc (IDIX), Alnylam Pharmaceuticals, Inc. (ALNY) & 3 Small Biotechs Top Hedge Funds Are Investing In

Idenix Pharmaceuticals Inc (NASDAQ:IDIX)
Small biotech companies have great investment potential if you can identify them properly. A small biotech with a differentiated treatment approach and......(read more)

Vertex Pharmaceuticals Incorporated (VRTX), Gilead Sciences, Inc. (GILD): The Week, Biotech – Part Two

As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector. A PDUFA decision, as well as three FDA panel reviews/findings......(read more)

Hedge Funds Are Selling ImmunoGen, Inc. (IMGN)

Kerr Neilson
ImmunoGen, Inc. (NASDAQ:IMGN) investors should pay attention to a decrease in hedge fund interest recently. At the moment, there are dozens of methods......(read more)

Do Hedge Funds and Insiders Love Synageva BioPharma Corp (GEVA)?

ynageva BioPharma Corp (NASDAQ:GEVA)
Synageva BioPharma Corp (NASDAQ:GEVA) has experienced an increase in hedge fund sentiment in recent months. At the moment, there are dozens of metrics......(read more)

Biogen Idec Inc. (BIIB): What Goes up Must Come Down

Biogen Idec Inc. (NASDAQ:BIIB) is one of those rare companies in the healthcare sector whose stock has relentlessly outperformed the broader market continuously......(read more)

Biopharma News: Theravance Inc (THRX), VIVUS, Inc. (VVUS), Amgen, Inc. (AMGN)

Theravance Inc (NASDAQ:THRX)
Editor’s Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc. (NASDAQ:AMGN), Acorda Therapeutics Inc (NASDAQ......(read more)

Roberto Mignone and Bridger Management’s Portfolio and New Stock Picks

BRIDGER MANAGEMENT
Roberto Mignone’s Bridger Management keeps their returns extremely secret. They do extensive analysis and follow a long/short strategy. Wall Street......(read more)
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 30 percentage points in 13 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!